Pharma & Biotech

While Zevra Therapeutics recently announced encouraging clinical results for its lead drug candidate, MIPLYFFA, its stock performance tells a contrasting...

Enanta Pharmaceuticals is navigating a significant leadership transition following the passing of its long-time Chief Financial Officer, Paul J. Mellett...

Lifecore Biomedical finds itself at a crossroads, navigating a complex landscape defined by strategic progress and immediate financial pressures. The...

Lyell Immunopharma has initiated a pivotal Phase 3 clinical trial for its lead CAR T-cell therapy, marking a significant strategic...

The biotechnology sector has found a standout performer in Incyte Corporation. While numerous competitors grapple for incremental growth, this company...

The investment narrative surrounding Denali Therapeutics presents a fascinating paradox. While its pipeline of therapies for neurodegenerative diseases generates significant...

Biopharmaceutical company NuCana faces a period of significant catalysts and challenges. With crucial clinical data on the horizon and a...

While Twist Bioscience delivered exceptional third-quarter financial results, its shares continue to face significant pressure from both legal proceedings and...

Bayer AG faces renewed pressure as a highly anticipated cardiovascular drug candidate failed to meet its primary endpoint in critical...

The corporate structure of Walgreens has undergone a fundamental transformation with the completion of its acquisition by private equity firm...